DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity
- 31 July 1997
- Vol. 15 (10) , 1049-1056
- https://doi.org/10.1016/s0264-410x(97)00045-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 41 references indexed in Scilit:
- Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env GeneThe Journal of Infectious Diseases, 1995
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Evidence of three HIV-1 subtypes in subgroups of individuals in ThailandThe Lancet, 1994
- Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infectionJournal of Molecular Recognition, 1993
- A Strategy for Prophylactic Vaccination Against HIVScience, 1993
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.The Journal of Experimental Medicine, 1992
- Cell-Mediated Immune Response to Human Immunodeficiency Virus (HIV) Type 1 in Seronegative Homosexual Men with Recent Sexual Exposure to HIV-1The Journal of Infectious Diseases, 1992
- Serum antibody directed against synthetic peptides derived from HIV-1 protein sequence obtained from 26 Japanese HIV-1-infected individualsAIDS, 1991
- Trans-activation of human immunodeficiency virus occurs via a bimodal mechanismCell, 1986